Elodie Lafargue

Elodie Lafargue

Auto-generated profile, based on publicly available information

Elodie Lafargue

U1325 Aix-Marseille Université, INSERM, DyNaMo, Turing Centre for Living System

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ELElodie Lafargue
Elodie Lafargue
JDJean-Pierre Duneau
Jean-Pierre Duneau
NBNicolas Buzhinsky
Nicolas Buzhinsky
POPamela Ornelas
Pamela Ornelas
AOAlexandre Ortega
Alexandre Ortega
LBLucie Bergdoll
Lucie Bergdoll
VDACs, the most abundant proteins in the outer mitochondrial membrane (MOM), are crucial for mitochondrial physiology. VDAC regulate metabolite and ion exchange, modulate calcium homeostasis, and play roles in numerous cellular events such as apoptosis, mitochondrial DNA (mtDNA) release, and different diseases. Mitochondrial function is closely tied to VDAC oligomerization, influencing key processes like mtDNA release and apoptosis, but the molecular drivers of this oligomerization remain unclear. In this study, we investigate the effects of three major MOM lipids on VDAC assemblies using atomic force microscopy and molecular dynamics simulations. Our results show that phosphatidylethanolamine and cholesterol regulate VDAC assembly, with the formation of stable lipid-protein organization of various size and compaction. Deviations from physiological lipid content disrupted native-like VDAC assemblies, highlighting the importance of lipid environment in VDAC organization. These findings underscore how lipid heterogeneity and changes in membranes influence VDAC function.

3 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
VRVarun Ravishankar
Varun Ravishankar
LBLuís Borges-Araújo
Luís Borges-Araújo
MRMegha Rajendran
Megha Rajendran
ELElodie Lafargue
Elodie Lafargue
DBDeborah Byrne
Deborah Byrne
LBLucie Bergdoll
Lucie Bergdoll
VDAC is the most abundant protein of the mitochondrial outer membrane and a key regulator of metabolite exchange and mitochondrial physiology. Its oligomerization has been proposed to control processes such as mitochondrial DNA release and membrane remodeling, yet the underlying mechanisms remain poorly defined. VBIT-4 has been widely used over the last decade as a putative inhibitor of VDAC1 oligomerization, despite limited mechanistic validation. Here, using high-speed atomic force microscopy, we directly visualized VDAC1 assemblies in lipid membranes and examined the effect of VBIT-4. Unexpectedly, VBIT-4 induced membrane defects and permeabilization at micromolar concentrations, independently of VDAC1. Quantitative AFM analysis further shows that VBIT-4 does not alter VDAC1 cluster organization. Complementary electrophysiology, microscale thermophoresis, and coarse-grained molecular dynamics demonstrate that VBIT-4 partitions into lipid bilayers, increases membrane permeability, and destabilizes membrane structure, without detectable effects on VDAC1 channel properties or oligomerization. Consistent with this mechanism, VBIT-4 induces VDAC1-independent cytotoxicity in HeLa cells at concentrations above 10 µM. Together, these results demonstrate that VBIT-4 does not act as a specific inhibitor of VDAC1 oligomerization but instead functions as a membrane-active compound. This work provides a revised framework for interpreting studies using VBIT-4 and highlights the importance of systematically assessing drug–membrane interactions when targeting membrane proteins.

9 October 2026 in eLife
Verified
Journal Article
Open access
VRVarun Ravishankar
Varun Ravishankar
LBLuís Borges-Araújo
Luís Borges-Araújo
MRMegha Rajendran
Megha Rajendran
ELElodie Lafargue
Elodie Lafargue
DBDeborah Byrne
Deborah Byrne
LBLucie Bergdoll
Lucie Bergdoll
Voltage-dependent anion channel (VDAC) is the most abundant protein of the mitochondrial outer membrane and a key regulator of metabolite exchange and mitochondrial physiology. Its oligomerization has been proposed to control processes such as mitochondrial DNA release and membrane remodeling, yet the underlying mechanisms remain poorly defined. VBIT-4 has been widely used as a putative inhibitor of VDAC1 oligomerization, despite limited mechanistic validation. Here, using high-speed atomic force microscopy (AFM), we visualized VDAC1 assemblies in lipid membranes and examined the effect of VBIT-4. Unexpectedly, VBIT-4 induced membrane defects and permeabilization at micromolar concentrations, independently of VDAC1. Quantitative AFM analysis further shows that VBIT-4 does not alter VDAC1 cluster organization. Complementary electrophysiology, microscale thermophoresis, and coarse-grained molecular dynamics demonstrate that VBIT-4 partitions into lipid bilayers, increases membrane permeability, and destabilizes membrane structure, without detectable effects on VDAC1 channel properties or assemblies. Consistent with this mechanism, VBIT-4 induces VDAC1-independent cytotoxicity in HeLa cells at concentrations above 10 µM. Together, these results demonstrate that VBIT-4 does not act as a specific inhibitor of VDAC1 oligomerization but instead functions as a membrane-active compound. This work provides a revised framework for interpreting studies using VBIT-4 and highlights the importance of systematically assessing drug-membrane interactions when targeting membrane proteins.

6 November 2026 in bioRxiv
Verified
Preprint
Open access
ELElodie Lafargue
Elodie Lafargue
NGNatalia Martin Gonzalez
Natalia Martin Gonzalez
AHAkiko Yamaji Hasegawa
Akiko Yamaji Hasegawa
TKToshihide Kobayashi
Toshihide Kobayashi
AGAdrian Carretero Genevrier
Adrian Carretero Genevrier
ICIgnacio Casuso
Ignacio Casuso
Beta porin toxins are virulence factors that oligomerize in host cell membranes, forming beta-barrel pores that permeabilize target cells, leading to osmotic imbalance, cell lysis, and immune evasion. Despite extensive research on beta-pore-forming toxins (PFTs), significant gaps remain in understanding their role as actors of large-scale supramolecular membrane remodeling. While beta-PFTs are traditionally viewed as passive cylindrical conduits, their biological efficacy is fundamentally tied to an evolved ability to structurally alter the host cell membrane. In this study, we combine erythrocytes, model membranes and a novel engineered nanopores on mica substrates. We overcome the limitation of traditional mica substrates and demonstrate that lysenin pores do not merely permeabilize the membrane; they curve it into rigid, dome-like supramolecular structures. Moreover, to gain biophysical insight beyond the standard membrane models which do not directly consider the membrane insertions, we propose a hybrid model combining the biophysical models and the architectural models of pendentive domes, where the intrinsic wedge-shaped geometry of the monomers is considered. Experimental mechanical assessment of the lysenins domes shows a non-linear mechanical of stiffness with respect the radius of curvature as predicted by our hybrid model. Collectively, our work suggests that the beta-PFTs induce membrane curvature by the assembly of wedges. Beyond their pore-forming function, this membrane-bending activity may represent an additional mechanism by which beta-PFTs interfere with host-cell membrane repair.